Effect of C60 Fullerene on Muscle Injury-Induced Rhabdomyolysis and Associated Acute Renal Failure
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s468013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Yuriy Prylutskyy und 10 weiteren Autor:innen. Beteiligte Einrichtung: ESC "institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine. Hauptthemen laut MEDLINE: Fullerenes, Rhabdomyolysis, Acute Kidney Injury, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Rhabdomyolysis, as an acute stage of myopathy, causes kidney damage. It is known that this pathology is caused by the accumulation of muscle breakdown products and is associated with oxidative stress. Therefore, the present study evaluated the effect of intraperitoneal administration (dose 1 mg/kg) of water-soluble C60 fullerenes, as powerful antioxidants, on the development of rat kidney damage due to rhabdomyolysis caused by mechanical trauma of the muscle soleus of different severity (crush syndrome lasting 1 min under a pressure of 2.5, 3.5, and 4.5 kg/cm2, respectively).
Methods
Using tensometry, biochemical and histopathological analyses, the biomechanical parameters of muscle soleus contraction (contraction force and integrated muscle power), biochemical indicators of rat blood (concentrations of creatinine, creatine phosphokinase, urea and hydrogen peroxide, catalase and superoxide dismutase activity), glomerular filtration rate and fractional sodium excretion value, as well as pathohistological and morphometric features of muscle and kidney damages in rats on days 1, 3, 6 and 9 after the initiation of the injury were studied.
Results
Positive changes in biomechanical and biochemical parameters were found during the experiment by about 27-30 ± 2%, as well as a decrease in pathohistological and morphometric features of muscle and kidney damages in rats treated with water-soluble C60 fullerenes.
Conclusion
These findings indicate the potential application of water-soluble C60 fullerenes in the treatment of pathological conditions of the muscular system caused by rhabdomyolysis and the associated oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ESC "institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
- Faculty of Biology and Forestry, Lesya Ukrainka Volyn National University, Lutsk, Ukraine.
- Faculty of Plant Protection, Biotechnology and Ecology, National University of Life and Environmental Science of Ukraine, Kyiv, Ukraine.
- Institute of Chemistry and Biotechnology, Technical University of Ilmenau, Ilmenau, Germany.
- Intercollegiate Faculty of Biotechnology, University of Gdansk, Gdańsk, Poland.
ORCID-Profile: Viktoria Stetska, Kateryna Bogutska, Jacek Piosik
Zitieren
APA
Prylutskyy, Y., Nozdrenko, D., Omelchuk, O., Prylutska, S., Motuziuk, O., Soroсa, V., Vareniuk, I., Stetska, V., Bogutska, K., Ritter, U., & Piosik, J. (2024). Effect of C60 Fullerene on Muscle Injury-Induced Rhabdomyolysis and Associated Acute Renal Failure. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s468013
Vancouver
Prylutskyy Y, Nozdrenko D, Omelchuk O, Prylutska S, Motuziuk O, Soroсa V, et al. Effect of C60 Fullerene on Muscle Injury-Induced Rhabdomyolysis and Associated Acute Renal Failure. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s468013
BibTeX
@article{Prylutskyy2024,
author = {Prylutskyy, Yuriy and Nozdrenko, Dmytro and Omelchuk, Olexandr and Prylutska, Svitlana and Motuziuk, Olexandr and Soroсa, Vasil and Vareniuk, Igor and Stetska, Viktoria and Bogutska, Kateryna and Ritter, Uwe and Piosik, Jacek},
title = {Effect of C60 Fullerene on Muscle Injury-Induced Rhabdomyolysis and Associated Acute Renal Failure},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s468013}
}
EUVIMED